CBP-307

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04700449 (ClinicalTrials.gov)	February 27, 2019	22/10/2020	A Study Assessing the Efficacy and Safety of CBP-307in Subjects With Moderate to Severe Ulcerative C ...	A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the ...	Moderate to Severe Ulcerative Colitis	Drug: CBP-307;Drug: Placebo	Suzhou Connect Biopharmaceuticals, Ltd.	NULL	Completed	18 Years	75 Years	All	145	Phase 2	United States;China;Pakistan;Ukraine

First Previous1Next Last